Multidrug-resistant bacterial infections and their clinical impact at the University Teaching Hospital of Kigali in
Jean Bosco Munyemana1,2, Nadine Nyishimente3, Samuel Rutare4
1Department of Microbiology and Parasitology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Introduction:
Multidrug-resistant (MDR) bacterial infections pose a serious global health threat, particularly in low-resource settings where empirical antimicrobial use is common, while associated with poor outcomes and increased resistance. This study evaluated the prevalence, resistance profiles, clinical impact, and treatment options for MDR bacterial infections at the University Teaching Hospital of Kigali, Rwanda.
Methods:
A retrospective descriptive-analytical study reviewed patient records and microbiology logbooks for culture-confirmed MDR infections from 1st January to 31st December 2023. Data were analyzed using SPSS, with significance set at p < 0.05.
Results:
Out of 1,676 positive cultures, 368 (22%) were MDR cases, mostly from surgical patients (30.4%). Urine samples yielded the majority of MDR isolates (52.2%), with Escherichia coli as the most common (45.4%), particularly in urine (71.3%). MDR isolates showed high resistance rates to ampicillin, doxycycline (100%), third-generation cephalosporins (98%), amoxicillin-clavulanic acid (96%), clindamycin (88%), and ciprofloxacin (74%). Resistance was lowest against amikacin (6%), vancomycin (14%), imipenem (24%), and polymyxin B (26%). The mean hospital stay was 8.6 days, and the mortality rate was 22% among patients with MDR bacterial infection.
Conclusion:
MDR bacterial infections were prevalent with longer hospital stays and poor outcomes. Despite high resistance to common antibiotics, amikacin, vancomycin, imipenem, and polymyxin B were effective treatment options. Continuous surveillance, antimicrobial stewardship, and treatment guideline development are crucial.
Discussion:
The global rise in antimicrobial resistance is a major public health threat requiring local surveillance for targeted interventions and guideline creation. This study at the University Teaching Hospital of Kigali found a 21.9% prevalence of MDR infections, reflecting global trends. Strengthening infection prevention and control and antimicrobial stewardship programs is needed to break transmission chains and optimize antimicrobial use.
Related Concept Videos
00:59Hospitals-II
Nurses that work in...
01:28Hospitals-I
01:25Endocarditis II: Clinical Features of Infective Endocarditis
01:30Pleural Disorders: Types and Brief Description
01:22Eulerian and Lagrangian Flow Descriptions
The Eulerian method focuses on fixed points in space where fluid properties, such as velocity, pressure, and temperature, are observed as the fluid moves between these...
01:33Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...